PERFUSE Registry: Diagnostic Accuracy Achieved with CT-Derived FFR Plus … – TCTMD (registration) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Intravenous immunoglobulin (IVIg) provides protection against endothelial cell … – 7thSpace Interactive (press release)

Good and Bad News Reported for Ovarian Cancer Therapy »

PERFUSE Registry: Diagnostic Accuracy Achieved with CT-Derived FFR Plus … – TCTMD (registration)

July 1, 2014 by 2012pharmaceutical

PERFUSE Registry: Diagnostic Accuracy Achieved with CT-Derived FFR Plus …

Source: www.tctmd.com

Posted in Scoop.it | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 1,062 other subscribers

Email Address
Recent Posts
- IBM has reached an agreement to sell its Watson Health data and analytics business to the private-equity firm Francisco Partners January 26, 2022
- Goal Attainment Scaling Record: 2021 – A Year in Review January 4, 2022
- Debbie Nickerson Dies at 67 – Greatest Loss to Genomic Sciences, yet January 3, 2022
- New studies link cell cycle proteins to immunosurveillance of premalignant cells December 16, 2021
- Global Alliance for Genomics and Health Issues Guidelines for Data Siloing and Sharing December 14, 2021
- UK Biobank Makes Available 200,000 whole genomes Open Access December 7, 2021
- FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism November 22, 2021
- Defective viral RNA sensing gene OAS1 linked to severe COVID-19 November 22, 2021
- Moderna Vaccine Patent Application needs to include Names of Three NIH Scientists that Shared the Genome Sequence of SAR-Cov-2 with Moderna Early on November 11, 2021
- Epidemiologic measurement on COVID-19 pandemic may have statistical biases which might affect next variant responses November 7, 2021
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: